Survival Prediction for Romanian Patients with Pancreatic Cancer
Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trial - The Lancet Oncology
Overall survival curves in patients with advanced pancreatic cancer... | Download Scientific Diagram
The difference of overall survival rates between 214 pancreatic cancer... | Download Scientific Diagram
Overall survival curves in patients with advanced pancreatic cancer... | Download Scientific Diagram
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine | NEJM
NAPOLI-1 phase 3 study of liposomal irinotecan in metastatic pancreatic cancer: Final overall survival analysis and characteristics of long-term survivors - European Journal of Cancer
Prognostic factors for survival with nab-paclitaxel plus gemcitabine in metastatic pancreatic cancer in real-life practice: the ANICE-PaC study | BMC Cancer | Full Text
Development and validation of a prognostic model to predict the prognosis of patients who underwent chemotherapy and resection of pancreatic adenocarcinoma: a large international population-based cohort study | BMC Medicine | Full
Overall survival and cancer-specific survival in patients with surgically resected pancreatic head adenocarcinoma: A competing risk nomogram analysis
Using adaptive magnetic resonance image‐guided radiation therapy for treatment of inoperable pancreatic cancer - Rudra - 2019 - Cancer Medicine - Wiley Online Library
Survival of pancreatic cancer patients is negatively correlated with age at diagnosis: a population-based retrospective study | Scientific Reports
![PDF] Systemic Immune Activity Predicts Overall Survival in Treatment-Naïve Patients with Metastatic Pancreatic Cancer | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/f8060d9899ce9ec36a13e67dd74a90e27110ae8b/5-Figure1-1.png "PDF] Systemic Immune Activity Predicts Overall Survival in Treatment-Naïve Patients with Metastatic Pancreatic Cancer | Semantic Scholar")
PDF] Systemic Immune Activity Predicts Overall Survival in Treatment-Naïve Patients with Metastatic Pancreatic Cancer | Semantic Scholar
MR-Guided Radiotherapy Prolongs Median Survival for Inoperable, Locally Advanced Pancreatic Cancer | Imaging Technology News
Survival of pancreatic cancer patients is negatively correlated with age at diagnosis: a population-based retrospective study | Scientific Reports
Overall survival in patients with pancreatic cancer according to the... | Download Scientific Diagram
Prognostic factors in patients with pancreatic cancer
CA19-9 decrease at 8 weeks as a predictor of overall survival in a randomized phase III trial (MPACT) of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone in patients with metastatic pancreatic cancer -
Figure 1 from Does neoadjuvant chemoradiation downstage locally advanced pancreatic cancer? | Semantic Scholar
Conditional Survival in Patients with Advanced Pancreatic Cancer | Insight Medical Publishing
Evaluation of the prognostic value of the new AJCC 8th edition staging system for patients with pancreatic adenocarcinoma; a need to subclassify stage III? - ScienceDirect
![Clinicopathologic characteristics, laboratory parameters, treatment protocols, and outcomes of pancreatic cancer: a retrospective cohort study of 1433 patients in China [PeerJ]](https://dfzljdn9uc3pi.cloudfront.net/2018/4893/1/fig-1-full.png "Clinicopathologic characteristics, laboratory parameters, treatment protocols, and outcomes of pancreatic cancer: a retrospective cohort study of 1433 patients in China [PeerJ]")
Clinicopathologic characteristics, laboratory parameters, treatment protocols, and outcomes of pancreatic cancer: a retrospective cohort study of 1433 patients in China [PeerJ]
Haemoglobin, albumin, lymphocyte and platelet predicts postoperative survival in pancreatic cancer
Proposal of predictive model on survival in unresectable pancreatic cancer receiving systemic chemotherapy
